These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 11150164)

  • 1. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
    Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
    Stauffer SR; Huang YR; Aron ZD; Coletta CJ; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):151-61. PubMed ID: 11197335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
    Mortensen DS; Rodriguez AL; Carlson KE; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2001 Nov; 44(23):3838-48. PubMed ID: 11689070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of estrogen receptor subtypes, ERalpha and ERbeta, mediating vitellogenin production in the liver of rainbow trout.
    Leaños-Castañeda O; Van Der Kraak G
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):116-25. PubMed ID: 17662327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor.
    Stauffer SR; Huang Y; Coletta CJ; Tedesco R; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):141-50. PubMed ID: 11197334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
    Meyers MJ; Sun J; Carlson KE; Marriner GA; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2001 Nov; 44(24):4230-51. PubMed ID: 11708925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus.
    Frasor J; Barnett DH; Danes JM; Hess R; Parlow AF; Katzenellenbogen BS
    Endocrinology; 2003 Jul; 144(7):3159-66. PubMed ID: 12810572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
    Mueller SO; Katzenellenbogen JA; Korach KS
    Steroids; 2004 Sep; 69(10):681-6. PubMed ID: 15465114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
    Muthyala RS; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2003 Apr; 46(9):1589-602. PubMed ID: 12699377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand.
    Harris HA; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2002 Nov; 143(11):4172-7. PubMed ID: 12399409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.
    Ohta K; Ogawa T; Kato K; Oda A; Endo Y
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2290-2293. PubMed ID: 31248773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
    Ghosh U; Ganessunker D; Sattigeri VJ; Carlson KE; Mortensen DJ; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2003 Feb; 11(4):629-57. PubMed ID: 12538029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.
    Paulmurugan R; Tamrazi A; Massoud TF; Katzenellenbogen JA; Gambhir SS
    Mol Endocrinol; 2011 Dec; 25(12):2029-40. PubMed ID: 22052998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential estrogen receptor subtype modulators: assessment of estrogen receptor subtype-binding selectivity and transcription-regulating properties of new cycloalkyl pyrazoles.
    Alexi X; Kasiotis KM; Fokialakis N; Lambrinidis G; Meligova AK; Mikros E; Haroutounian SA; Alexis MN
    J Steroid Biochem Mol Biol; 2009 Nov; 117(4-5):159-67. PubMed ID: 19772920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
    Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
    Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
    Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.